Joshua Riezman - 14 Nov 2025 Form 4 Insider Report for Lite Strategy, Inc. (MEIP)

Reporting relationship: Director
Issuer ticker: MEIP
Reported as of: 14 Nov 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Nov 2025, 17:09:07 UTC
Prior SEC filing: 20 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ Justin J. File, as Attorney-in-fact for the Reporting Person

Key filing fact

Joshua Riezman filed Form 4 for Lite Strategy, Inc. (MEIP) on 18 Nov 2025.

Key facts

This page summarizes Joshua Riezman's Form 4 filing for Lite Strategy, Inc. (MEIP).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 18 Nov 2025, 17:09.

Change

Previous filing in this sequence was filed on 20 Aug 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002082518 Primary reporting owner

Riezman Joshua

Relationship: Director
Address: C/O LITE STRATEGY, INC., 9920 PACIFIC HEIGHTS BLVD., SUITE 150, SAN DIEGO
Signature: /s/ Justin J. File, as Attorney-in-fact for the Reporting Person
Signature date: 18 Nov 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LITS transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +55,000
Change %
Price
Shares after: 55,000
Date: 14 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 55,000
Exercise price: $2.02
Footnotes: F1, F2

LITS transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +10,000
Change %
Price
Shares after: 10,000
Date: 14 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $2.02
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Customary annual grant to non-employee directors of options to purchase shares of common stock. Such options shall vest as follows: 16.66666% shall be vested on the date of grant, and the remaining shares subject to the option shall vest in monthly amounts beginning December 14, 2025 and continuing on the first day of each calendar month following such date and continuing through November 14, 2026.

Footnote F2

Received as compensation for service on the Board.

Footnote F3

Customary grant upon appointment of non-employee directors to our Board as revised on November 14, 2025, less options to purchase shares of common stock previously made to Mr. Riezman on August 8, 2025. Such options shall vest and become exercisable in 36 monthly installments, with the first installment vesting on the one-month anniversary of the date of grant, subject to continued service through the applicable vesting date.